1. Home
  2. LXRX vs SGC Comparison

LXRX vs SGC Comparison

Compare LXRX & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • SGC
  • Stock Information
  • Founded
  • LXRX 1995
  • SGC 1920
  • Country
  • LXRX United States
  • SGC United States
  • Employees
  • LXRX N/A
  • SGC N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • LXRX Health Care
  • SGC Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • SGC Nasdaq
  • Market Cap
  • LXRX 273.9M
  • SGC 281.4M
  • IPO Year
  • LXRX 2000
  • SGC N/A
  • Fundamental
  • Price
  • LXRX $0.69
  • SGC $15.78
  • Analyst Decision
  • LXRX Buy
  • SGC Strong Buy
  • Analyst Count
  • LXRX 2
  • SGC 2
  • Target Price
  • LXRX $6.00
  • SGC $22.50
  • AVG Volume (30 Days)
  • LXRX 5.0M
  • SGC 40.2K
  • Earning Date
  • LXRX 03-10-2025
  • SGC 03-12-2025
  • Dividend Yield
  • LXRX N/A
  • SGC 3.55%
  • EPS Growth
  • LXRX N/A
  • SGC 79.86
  • EPS
  • LXRX N/A
  • SGC 0.82
  • Revenue
  • LXRX $5,229,000.00
  • SGC $567,509,000.00
  • Revenue This Year
  • LXRX $842.94
  • SGC $5.29
  • Revenue Next Year
  • LXRX $19.76
  • SGC $3.87
  • P/E Ratio
  • LXRX N/A
  • SGC $19.26
  • Revenue Growth
  • LXRX 886.60
  • SGC 4.19
  • 52 Week Low
  • LXRX $0.62
  • SGC $11.66
  • 52 Week High
  • LXRX $3.73
  • SGC $21.80
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 40.93
  • SGC 46.58
  • Support Level
  • LXRX $0.70
  • SGC $14.96
  • Resistance Level
  • LXRX $0.75
  • SGC $16.38
  • Average True Range (ATR)
  • LXRX 0.08
  • SGC 0.58
  • MACD
  • LXRX -0.00
  • SGC -0.00
  • Stochastic Oscillator
  • LXRX 7.14
  • SGC 44.61

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: